Guyana vs Iran: Immunization, Hib3 (% of children ages 12-23 months)
Guyana
98.0%
in 2024
Iran
98.0%
in 2024
Guyana rank
20th
Iran rank
20th
Immunization, Hib3 (% of children ages 12-23 months) over time
- Guyana
- Iran
How they compare
Guyana currently reports 98.0% against 98.0% in Iran, a difference of 0.0%.
Across all 10 years both countries report, Iran has been ahead every year.
Guyana ranks 20th and Iran ranks 20th of 191 countries.
Iran has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Guyana | Iran | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 96.6% | 98.8% | 2.2% | Iran |
| 2020s | 98.2% | 98.6% | 0.4% | Iran |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher immunization, hib3, Guyana or Iran?
- Guyana, at 98.0% against 98.0% in Iran as of 2024.
- What is the difference in immunization, hib3 between Guyana and Iran?
- 0.0%, with Guyana ahead.
- How many years of comparable data are there for Guyana and Iran?
- 10 years are reported by both, from 2015 to 2024.
- How do Guyana and Iran rank globally for immunization, hib3?
- Guyana ranks 20th and Iran ranks 20th of 191 countries.
- Where does this data come from?
- WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/), published as Immunization, Hib3 (% of children ages 12-23 months). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Child immunization, Hib3, measures the percentage of children ages 12-23 months who received Hib3 vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized against Hib3 after receiving three doses of Haemophilus influenzae type b vaccine.